The Life Sciences and Diagnostics draw a wider range of subject lines from the cellular and bimolecular process of living beings, and agriculture to the formulation of drugs, industrial enzymes and in-vitro diagnostics, and many more to fit in.
We are dealing with several submarket topics in this domain and provide an accurate research report and analysis. Along with the new emerging fields like, genomics, proteomics, bioinformatics, biomarkers, biomaterials, and biosimilars, we are working on the agriculture sectors and the formulation of new grades of biofuels, which is currently the market attention.
Different types of services in diagnostics are currently provided by us, like: Clinical Diagnostics, Laboratory Diagnostics, Radiological Diagnostics, Differential Diagnostics, Exclusion Diagnostics, Remote Diagnostics, Stem cell market, Biobanking market, Molecular market and diagnostics, Fermenters and bioreactors, Fertilizers, pesticides, fungicides and agrobiochemicals, and many more relevant life science and diagnostic components are a part of our research service.
We classify our Life Science-IT market according to geographical sectors, companies, end-users, macro indicators and submarkets. The geographical range strand othershes from India to all over the world and the physicians with offices, medical and diagnostic laboratories, hospitals, emergency healthcare service providers, nurses, and leading life sciences and diagnostic companies are all the end-users.
3D Cell Culture Market by Technology (Scaffold-based, Scaffold free, Microfluidic, Magnetic levitations & 3D bio printing, Others), by Application (Stem Cell Research, Drug Discovery and Development, Tissue Engineering and Regenerative Medicine, Neuroscience, Other Applications), by Cultural Component (Culture Media, Reagents and Consumables), by End User (Academic and Research Institutes, Clinical and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies) Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global 3D Cell Culture Market size is estimated to be USD 844.2 million in 2019 and is predicted to reach USD 3637.4 million by 2030 with a CAGR of 14.2% from 2020-2030. Cell culture techniques are unique and effective in the areas of developmental biology, drug discovery, regenerative medicine and protein production. 3D cell culture is an artificially created environment for adequate growth a Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biologics Market by Type (Therapeutic Proteins, Monoclonal MAbS, Vaccines, Antisense, RNAi, & Molecular Therapy, and Others), by Manufacturing Capabilities (In-house and Outsourced), by Source (Microbial, Mammalian, and Others), by Route of Administration (Oral and Others), by Application (Hematologic Disorders, Infectious Diseases, Immunological Disorders, Oncology, Cardiovascular Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Mode of Purchase (Prescription Drugs and OTC Drugs) - Global Opportunity Analysis and Industry Forecast, 2022–2030 (Upcoming Report)
Market Definition:
The Biologics Market size was valued at USD 322.80 billion in 2021, and is predicted to reach USD 689.59 billion by 2030, with a CAGR of 8.8% from 2022 to 2030.
Biologics are also known as biological drugs. They are disease-modifying drugs made from living organisms or part of living organisms. These drugs are derived from humans, insects, birds, plants, and microorganism Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Bio production CMO & CRO Market by Products (Biologics, Antisense, RNAi, & Molecular Therapy And Bio similar) by Services (Contract Manufacturing And Contract Research) by Application (Oncology, Inflammation & Immunology, Cardiology, Neuroscience) Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Bio production CMO & CRO Market size is estimated to be USD 24.20 billion in 2019 and is predicted to reach USD 51.46 billion by 2030 with a CAGR of 7.1% from 2020-2030. The pharmaceutical and biotechnology companies are currently focusing on outsourcing their research and development, manufacturing and distribution needs to contract manufacturers and contract research organizations Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Recombinant Peptides) by Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders) Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Biosimilars Market size is estimated to be USD 10.54 billion in 2019 and is predicted to reach USD 263.57 billion by 2030 with a CAGR of 34.0% from 2020-2030. Biosimilars are exactly what its name implies. These are biologics that are similar to other biologic drug that is already present in the market. Any differences between the reference drug and the biosimilars can impact the Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biotechnology Market by Technology (Tissue Engineering and Regeneration, PCR Technology, Fermentation, Chromatography, DNA Sequencing, Cell-Based Assays, Nanobiotechnology, and Others), and by Application (Bio-services, Bio-agriculture, Bio-Industrial, Bio-pharmacy, and Bioinformatics) – Global Opportunity Analysis and Industry Forecast, 2023 – 2030 (Upcoming Report)
Market Definition
The global Biotechnology Market size was valued at USD 1.13 billion in 2022 and is predicted to reach USD 4.15 billion by 2030 with a CAGR of 20.4% from 2023 to 2030.
Biotechnology is an interdisciplinary field that uses living creatures, biological systems, or derivatives to improve or develop procedures and outcomes to produce healthcare products and therapies. It h Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Blood Culture Test Market by Product (Software & Services, Consumables, and Instruments), by Technology (Culture Based Technology, Molecular Technology, Proteomic Technology, Microarrays, Polymerase Chain Reaction, and PNA-FISH), by Method (Automated Method and Conventional /Manual Method), by Application (Fungal, Micro-Bacterial, and Bacterial), and by End User (Academic Research Laboratories, Reference Laboratories, Hospitals & Diagnostic Centers, and Others) – Global Opportunity Analysis and Industry Forecast 2023 - 2030 (Upcoming Report)
Market Definition
The global Blood Culture Test Market size was valued at USD 5.48 billion in 2022 and is predicted to reach USD 10.39 billion by 2030 with a CAGR of 9.57% from 2023 to 2030.
A blood culture test is a kind of laboratory test that examines microorganisms in the blood. The microorganisms may include bacteria, fungus, and viruses. It is performed by using a variety of devi Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives), by Antithrombotic & Anticoagulant Type (Inhibitors, Platelet Aggregation, and Fibrinolytics), by Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others), and by End User (Hospitals, Clinics, Diagnostic Centers, Research Labs, Blood Banks, Pharmaceuticals, and Others) – Global Opportunity Analysis and Industry Forecast 2023 - 2030 (Upcoming Report)
Market Definition
The global Blood Preparation Market size was valued at USD 46.88 billion in 2022 and is predicted to reach USD 72.94 billion by 2030 with a CAGR of 5.69% from 2023 to 2030. Blood preparation refers to the process of collecting, testing, processing, and storing blood and blood components for transfusion or therapeutic use. This involves screening for infectious diseas Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Breast Biopsy Market by Type (Needle Biopsy (CNB, FNAB, VAB), Liquid Biopsy (CTC, ctDNA)), by Product (Needles, Tables, Assay Kit), by Guidance (Image-Guided (Mammography, Ultrasound, MRI), Liquid Biopsy (NGS, PCR, Microarray-based)) and by Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring)- Global Opportunity Analysis and Industry Forecast, 2022–2030 (Upcoming Report)
Market Definition:
The Breast Biopsy Market size was valued at USD 700.60 million in 2021, and is predicted to reach USD 1082.44 million by 2030, with a CAGR of 5.1% from 2022 to 2030.
Breast biopsy is a medical technique of collecting specimen samples of breast tissue or fluid to diagnose breast cancer and other diseases through laboratory testing. This technique is performed when symptoms Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Bone Grafts and Substitutes Market by Type (Bone Graft Substitutes, Allograft, Cell-based Matrices), Material Type (Collagen, Human Cell Source, Animal Source, Hydroxyapatite, Tricalcium Phosphate, Others), Application (Spinal Fusion, Trauma, Dental Bone Grafting, Craniomaxillofacial, Joint Reconstruction) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition
The global Bone Grafts and Substitutes Market size valued USD 2.96 billion in 2019, and is predicted to reach USD 4.85 billion by 2030, witnessing a CAGR of 4.5% from 2020-2030. Bone grafting is a surgical procedure to operate extremely complicated bone fractures whereas bone grafts are implantable materials, used during the procedure to promote bone healing, bone formati Publish Date: Jun 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition
The Global Cancer Gene Therapy Market size valued to USD 558.24 billion in 2019, is predicted to reach USD 16.50 billion by 2030, with a CAGR of 32.6% from 2020-2030.
Gene therapy is a technique to treat or prevent diseases, by using specific genes to replace the mutated gene causing disease or inactivate the mutated gene not functioning properly, or introducing an entirely Publish Date: Feb 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
Coverall Market by Type (Durable and Disposable), by Fabric (Cotton, Polyester, PVC, Mixed, and Others), by Type of Protection (Chemical Protection, Flame Retardant Protection, and Others), by Sales Channel (Online Stores, Specialty Stores, and Distributors), and by Application (Agriculture, Construction, Mining, Manufacturing Services, Chemical, Oil & Gas, Healthcare, Pharmaceuticals, and Others) – Global Opportunity Analysis and Industry Forecast 2023-2030 (Upcoming Report)
Market Definition
The global Coverall Market size was valued at USD 2.14 billion in 2022 and is predicted to reach USD 3.63 billion by 2030 with a CAGR of 7.9% from 2023-2030. Coverall is a type of protective clothing that covers the body from head to toe. It is usually made of a lightweight, breathable fabric such as cotton, polyester, vinyl, and Tyvek. Coverall protects the entire b Publish Date: Oct 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Legionella Water Testing Market by Test Type (Water Testing, IVD Testing), by Application (Clinical Testing Methods, Environmental Testing Methods, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, Others)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Legionella Water Testing Market size is estimated to be USD 220.9 billion in 2019 and is predicted to reach USD 509.9 billion by 2030 with a CAGR of 7.9% from 2020-2030. Legionella is the bacteria which is responsible for Legionellosis, a form of pneumonia. The treatment requires intensive care and hospitalization thus is considered as one of the major public concern.
Market Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Malaria Diagnostics Market by Technology (Clinical Diagnostics, Microscopic Diagnostic, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Test and other Technologies), by End user (Hospitals, Clinics, Blood Banks and Diagnostic Centers) - Global Opportunity Analysis and Industry Forecast 2022-2030 (Upcoming Report)
Market Definition:
The Malaria Diagnostics Market size was valued at USD 785.04 million in 2021 and is predicted to reach USD 1,197.13 million by 2030 with a CAGR of 4.8% from 2022-2030.
Malaria is an infection caused by parasites, which is highly fatal if it is left untreated. This disease spreads through the bite of infected female Anopheles mosquito that leads to transfer of plasmodium p Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Minimally Invasive Surgery Market by Service Type (Laparoscopic Surgery and Robotic Surgery), by Product Type (Surgical Devices, Monitoring and Visualization Systems, Laparoscopy Devices, Endosurgical Equipment, and Electrosurgical Equipment), by Technology (Transcatheter Surgery, Laparoscopy Surgery, Non-Visual Imaging, and Medical Robotics), by Application (Gastrointestinal Surgery, Urology Surgery, Cosmetic Surgery, Orthopaedic & Spine Surgery, Cardiac Surgery, Cancer Surgery, Obesity Surgery, and Others) and by End-User (Hospitals, Clinics, Individual Surgeons, Academic & Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2024–2030 (Upcoming Report)
Market Definition
The Minimally Invasive Surgery Market size was valued at USD 44.90 billion in 2023 and is predicted to reach USD 71.34 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. Minimally invasive surgery (MIS), also known as laparoscopic surgery or keyhole surgery, is a medical procedure that uses small incisions and specialized instruments to perform operations on the body. Publish Date: Oct 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Global Orthodontics Market by Type (Brackets, Anchorage Appliances, Ligatures and Archwires) and Age Group (Adults and Children) – Global Opportunity Analysis and Industry Forecast 2020-2030 (Upcoming Report)
Market Definition:
The global Orthodontics Market was valued at USD 1.87 billion in 2019 and is predicted to reach USD 4.32 billion by 2030 with a CAGR of 7.9% from 2020-2030.
Orthodontics is a branch of dentistry that deals with the prevention, diagnosis and correction of malocclusion of teeth as well as misaligned jaw pattern. This not only improves the oral health but also enhances the o Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Pathological Examination Market by Type (Conventional pathology and Digital Pathology), by Application (Digestive Organs, Blood and others), by End Users (Hospitals, clinics and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Pathological Examination Market size is estimated to be USD 186.23 billion in 2019 and is predicted to reach USD 654.20 billion by 2030 with a CAGR of 12.1% from 2020-2030. Pathological Examination is a diagnostics procedure which involves the study of body fluids such as blood, urine, tissues and others. This examination helps to identify the disease and its extent, cause and response Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Donor Eggs IVF Services Market by Cycle Type (Fresh Donor Egg IVF Cycle and Frozen Donor Egg IVF Cycle), by End User (Fertility Clinics, Surgical Centers, Hospital, Clinical Research Institutes)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition:
The Global Donor Eggs IVF Services Market size valued to USD 1.95 billion in 2019, is predicted an elevation of USD 4.83 billion by 2030, witnessing a CAGR of 8.6% from 2020-2030.
Donor eggs IVF service is type of an Assisted Reproduction Treatment, where egg donated by a healthy female donor, is fertilized in vitro with a healthy sperm, outside the body, in favorable labo Publish Date: Oct 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
Healthcare Artificial Intelligence Software Market by Offering (Hardware, Software and Service), by Algorithm (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), by Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), by End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Healthcare Artificial Intelligence Software Market size is estimated to be USD 4.68 billion in 2019 and is predicted to reach USD 354.47 billion by 2030 with a CAGR of 48.2% from 2020-2030. Artificial Intelligence Software can be defined as adopted intelligence which has problem solving skills and other by the helps of science and engineering. Artificial intelligence has a wide applicat Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Bioinformatics Market by Products and Services (Knowledge Management Tools, Bioinformatics Platform, and Bioinformatics Services), by Applications (Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics, and Other Applications) By End-Use (Pharmaceutics, Animal Study, Agriculture, Forensic Science, Other) - Global Opportunity Analysis and Industry Forecast 2022-2030 (Upcoming Report)
Market Definition
The global Bioinformatics Market was valued at USD 9.36 billion in 2021 and is predicted to reach USD 26.86 billion by 2030 with a CAGR of 12.7% from 2022-2030. Bioinformatics is an interdisciplinary field that combines biology, computer science, mathematics, and statistics to analyze and interpret biological data. It involves the development and application of computatio Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Bioprocessing Market by Products (Biopharmaceuticals, Industrial Enzymes, Biofuels, and Biomaterials), and by Application (Pharmaceuticals, Biotechnology, Food & Beverages, Agriculture & Animal Feed, Environment & Waste Management, and Other Industrial Applications)- Global Opportunity Analysis and Industry Forecast 2022-2030 (Upcoming Report)
Market Definition
The global Bioprocessing Market was valued at USD 17.66 billion in 2021 and is predicted to reach USD billion 44.19 by 2030 with a CAGR of 11.0% from 2022-2030.
Bioprocessing refers to the use of biological systems, living organisms, or enzymes for specific industrial or manufacturing processes. This process includes fermentation, cell cultivation, purification, and downst Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biosimulation Market by Type, (Large-Scale Biosimulation and Small-Scale Biosimulation), by Component (Software and Services), by Application (Drug Development, Drug Discovery, Pre-Clinical Testing, and Other), by Delivery (Subscription and Ownership), and by End User (Contract Research Organizations (CROS), Pharmaceutical & Biotechnology Companies, Regulatory Authorities, and Academic & Research Institutes) – Global Opportunity Analysis and Industry Forecast 2023 – 2030 (Upcoming Report)
Market Definition
The global Biosimulation Market size was valued at USD 1.79 billion in 2022 and is predicted to reach USD 6.83 billion by 2030 with a CAGR of 18.25% from 2023 to 2030.
Biosimulation is a scientific discipline that involves use of computer models to simulate and analyze complex biological systems. It uses mathematical and computational models to describe and predict th Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biological Safety Testing Market by Product (Consumables, Kits & Reagents, Instruments, and Services), by Test Type (Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Adventitious Agent Detection Tests), by Application (Blood & Blood-Based Products, Cellular and Gene Therapy, Vaccines & Therapeutics, Tissue & Tissue-Related Products Testing, and Stem Cell Research) and by End User (Contract Development & Manufacturing Companies, Research & Academia, Pharmaceutical, and Biotechnology Companies)- Global Opportunity Analysis and Industry Forecast 2023 – 2030 (Upcoming Report)
Market Definition
The global Biological Safety Testing Market size was valued at 3.98 billion in 2022 and is predicted to reach 8.76 billion by 2030 with a CAGR of 10.4% from 2023 to 2030.
Biological safety testing is performed to ensure non-contamination of biological products such as drugs, therapeutics, and vaccines. Biological products are manufactured from living organisms such as Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Bioprosthetics Market and by Type (Xenograft, Allograft, and Tissue Source), and by Application (Wound Healing, Cardiovascular, Cosmetic Surgeries, and Orthopedics) – Global Opportunity Analysis and Industry Forecast 2023 – 2030 (Upcoming Report)
Market Definition
The Bioprosthetics Market size was valued at USD 5.40 billion in 2022, and is predicted to reach USD 12.36 billion by 2030 with a CAGR of 10.85% from 2023 to 2030.
Bioprosthetics are non-synthetic implants that are made from human or animal tissue, which are used for medical procedure. It is a procedure of inserting an implantable medical device used for patients suffering Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Culture Media Market by Type (Lysogeny, Broth, Chemically Defined Media, Classical Media, Serum-free Media, Specialty Media, Stem Cell Media, Custom Media Formulation, and Others), by Research Type (Cytogenetics, Cell Therapy, and Others), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies, Drug Discovery, and Others), by End Users (Biotechnology & Pharmaceutical Industry, Academic Institute, Research Laboratory, and Others) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
The Global Culture Media Market size is estimated to be USD 4.74 billion in 2019 and is predicted to reach USD 10.83 billion by 2030 with a CAGR of 7.8% from 2020-2030. Culture Media consist of vitamins, minerals, amino acids and other essential nutritional elements which help in microbial growth. These media are used in laboratories and research centers for the microbial, bacterial and fungal gro Publish Date: Dec 2019
Single User:
3975 3776
Multi Users:
4975 4726
|
Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Global Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
The global Early Toxicity Testing (ETT) Market size was valued at USD 8.92 billion in 2022 and is predicted to reach USD 14.39 billion by 2030, registering a CAGR of 5.3% from 2023 to 2030. Early toxicity testing is a process that involves evaluating the potential toxicity or adverse effects of drugs, chemicals, or other substances at an early stage of development, typica Publish Date: May 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Eye-Drop and Lubricants Market by Type (Antibiotics, Hormones, Artificial Tears, and Others), by Application (Eye Diseases, Eye Care and Others) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Eye-Drop and Lubricants Market size is estimated to be USD 16.98 billion in 2019 and is predicted to reach USD 27.27 billion by 2030 with a CAGR of 4.4% from 2020-2030. Eye-Drop and Lubricants are the special formulation made for the treatment of various eye conditions such as dry eye, conjunctivitis, macular degeneration and others. It also helps in the preservation of eye sight and al Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Medical Videoscope Market by Product Type (Videoscopes and Visualization & Documentation Systems), by Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, and Others), by End User (Hospitals, Clinics and others)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Medical Videoscope Market size is estimated to be USD 22.36 billion in 2019 and is predicted to reach USD 44.14 billion by 2030 with a CAGR of 5.7% from 2020-2030. Medical Videoscope are the medical devices consist of small camera at the tip with optical fibers. There allows to carry out the diagnostic procedures of hollow cavities by interventions. These devices are generally used for Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Pneumonia Vaccines Market by Type (Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine), by Product (Prevnar 13, Synflorix, Pneumovax 23, and Others), by Sector (Public and Private Sector), by Age Group (Adults and Pediatrics) and by Distribution Channel (Distribution Partner Companies, Non-governmental Organizations, Public Health Agencies, Community Clinics and Others) - Global Opportunity Analysis and Industry Forecast 2022-2030. (Upcoming Report)
Market Definition
The global Pneumonia Vaccines Market size was valued at USD 8.76 billion in 2021 and is predicted to reach USD 15.46 billion by 2030 with a CAGR of 6.52% from 2022-2030. Pneumonia vaccines protect paediatrics and adults against pneumococcal bacterial strains by stimulating the immune system. These vaccines prevent the spreading of pneumonia and further eliminate hospitali Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Genetic Testing Market by Type (Predictive Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), by Technology (Cytogenetic Testing/ Chromosome Analysis, Biochemical Testing, and Molecular Testing), by Application (Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Genetic Testing Market size is estimated to be USD 9.25 billion in 2019 and is predicted to reach USD 29.44 billion by 2030 with a CAGR of 11.1% from 2020-2030. Genetic Testing is the study of genetics which is used in the biology or life science for the better understanding of genetic disorders such as sickle cell anemia, Down ’s syndrome and others. This also helps in the develo Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Smoke Evacuation System Market by Type (Smoke Evacuating Systems, Smoke Evacuation Filters, Smoke Evacuation Pencils & Wands, Smoke-Evac Fusion Products (Shrouds), Smoke Evacuation Tubings, and Accessories), by Application (Laparoscopic Surgeries, Open General Surgeries, Medical Aesthetic Surgeries, and Orthopedic Surgeries), by End User (Hospitals, Ambulatory Surgical Centers, Cosmetic Surgery Centers, Dental Clinics, and Veterinary Healthcare Providers) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
The Global Smoke Evacuation System Market size is estimated to be USD 165.3 million in 2019 and is predicted to reach USD 323.7 million by 2030 with a CAGR of 6.3% from 2020-2030. Smoke Evacuation System is used in the surgical room to remove the smoke produces at the surgical site. The smoke is generally produced during tissue ablation, electrosurgery, drilling and others as a by-product. It is i Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Surgical Imaging Market by Modality Type (Mobile C-Arms, Mini C-Arms, and Others), Technology Type (Image Intensifier, and Flat Panel Detector (FPD)), and Application (Neurosurgery, Orthopedic & Trauma Surgery, Cardiovascular Surgery, General Surgery, Other surgeries) - Global Opportunity Analysis and Industry Forecast, 2021 – 2030 (Upcoming Report)
Market Definition:
Global Surgical Imaging Market size was valued at USD 1.16 billion in 2020 and is predicted to reach USD 1.71 billion by 2030 with a CAGR of 3.9% from 2021-2030.
Surgical imaging is an optical imaging technology mainly used for image-guided surgery. It includes various tools for planning, diagnosis, computed tomography (CT), magnetic resonance Imaging (MRI), MR therapy (M Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Surgical Suite Market by Component (Software and Services), by Type (Display Systems, Document Management Systems, Audio & Video Management Systems, Integration Devices, and Others), by Application (General Surgery, Orthopaedic Surgery, Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, and Other Applications), and by End User (Hospitals, Ambulatory Surgical Centres, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2023–2030 (Upcoming Report)
Market Definition
The global Surgical Suite Market size was valued at USD 1.95 billion in 2022 and is predicted to reach USD 4.78 billion by 2030 with a CAGR of 19.6% from 2023-2030.
A surgical suite is a facility where patients undergo surgical treatments and procedures to treat or diagnose variety of pathological and physiological disorders. It provides secure and sterile environment Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Testosterone Gel Market by Type (1% Solution and 1.62% Solution), by Dosage (5mg and 10mg), by Application (Primary hypogonadism, Hypogonadotropic hypogonadism, and Late-Onset Hypogonadism), by Distribution Channel (Hospital Pharmacies and Retail Pharmacies)- Global Opportunity Analysis and Industry Forecast 2023-2030 (Upcoming Report)
Market Definition
The global Testosterone Gel Market size was valued at USD 1.81 billion in 2022 and is predicted to reach USD 2.96 billion by 2030 with a CAGR of 6.3% from 2023-2030. Testosterone gel is a topical therapy that addresses hormonal imbalances in men with hypogonadism, a condition in which the body does not produce enough natural testosterone. Testosterone is a male hormone th Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Wound Care Market by Product (Dressings, Devices, Grafts, Matrices, Topical Agents, Sutures, and Stapler), by Product Type (Advanced Wound Dressing, Traditional Wound Care, Negative Pressure Wound Therapy, Bioactives, and Others), by Application (Chronic Wounds and Acute Wounds), and by End-Users (Hospitals, Clinics, Homecare Settings, Long-term Care Facilities, and Others) - Global Opportunity Analysis and Industry Forecast 2023-2030 (Upcoming Report)
Market Definition
The global Wound Care Market size was valued at USD 18.40 billion in 2022 and is predicted to reach USD 27.9 billion by 2030 with a CAGR of 5.3% from 2023-2030. Wound care refers to the wide range of products or therapies that are required to treat wounds caused due to injury or surgery. It also includes healing of chronic wounds such as diabetic ulcers, venous leg ulcers Publish Date: Nov 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Cardiac Biomarkers Market by Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Point of Care Testing and Laboratory Testing) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition
The global Cardiac Biomarkers Market size was valued at USD 8.42 billion in 2019 and is predicted to reach USD 28.29 billion by 2030, with a CAGR of 11.6% from 2020-2030.
Cardiac biomarkers are protein-based substrates released into the blood stream when the heart is extremely stressed or damaged. Cardiac biomarkers can be traced and measured to diagnose Cardio Vascular Dis Publish Date: Sep 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
Companion Diagnostics Market by Technology Type (Immunohistochemistry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In Situ Hybridization and Others), by Indication (Oncology, Neurology and Others)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition
The global Companion Diagnostics Market size was valued at USD 1.96 billion in 2019 and is predicted to reach USD 9.02 billion by 2030, with a CAGR of 14.8% from 2020-2030.
Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug for screening the responders and non-responders to that particular drug. It is done in order to identify a patient group Publish Date: Jan 2021
Single User:
3975 3776
Multi Users:
4975 4726
|
Endodontic Consumables Market by Product (Endodontic File, Obturator, and Permanent Endodontic Sealer), by End User (Dental Clinic, Hospital and Dental Academic Research Institute) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition
The global Endodontic Consumables Market size was valued at USD 1.40 billion in 2019, is predicted to garner USD 2.34 billion by 2030, witnessing a CAGR of 4.8% from 2020-2030.
Endodontics consumables hold an integral part in dental procedures such as endodontic therapy, endodontic surgery, retreatment, dental trauma, and treatment of cracked teeth. These consumables are wi Publish Date: Jun 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
External Defibrillators Market by Product Type (Manual External Defibrillator, Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD)), by End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, and Home)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Defination:
The Global External Defibrillators Market size was valued at USD 5.67 billion in 2019, and is predicted to reach USD 11.01 billion by 2030, with a CAGR of 6.1% from 2020-2030.
The global sale of External Defibrillators was 3.11 million units in 2019, which is projected to escalate by 9.50 million units by 2030, with a CAGR of 10.7%, from 2020-2030.
External defibrillato Publish Date: Oct 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles), by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
Market Definition
The global IVF Services Market size valued to USD 13.63 billion in 2019, shall elevate to USD 35.53 billion by 2030, witnessing a CAGR of 9.1% from 2020-2030.
IVF (In Vitro Fertilization) is a type of Assisted Reproductive Technology (ART), where female ovum retrieved from the ovaries fertilize with quality male sperm, under artificial laboratory conditions, in a vitro (gla Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Multiplex Assay Market by Type (Nucleic Acid-based Multiplex Assays, Protein-based Multiplex Assays, and Others), by Product (Multiplex Assay Reagents & Consumables, Multiplex Assay Instruments & Accessories, and Multiplex Assay Software & Services), by Technology (Multiplex PCR, Multiplex Protein Microarray, and Others), by Application (Companion Diagnostics, Research & Development, and Clinical Diagnostics), by End User (Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
Market Definition:
The Global Multiplex Assay Market size was valued at USD 77.8 million in 2019, and is predicted to reach USD 153.9 million by 2030, with a CAGR of 6.4% from 2020-2030.
In a multiplex assay test, multiple analytes are simultaneously measured in a single experiment, thereby amplifying multiple targets in a single PCR (Polymerase Chain Reaction). Multiple assay test collects Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Vital Organs Support Systems and Medical Bionics Market by Vital Organ Support Systems (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Urinary Bladder, Artificial Lungs, and Artificial Liver), by Medical Bionics (Bionic Eye, Ear Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics), by End User (Hospitals, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Upcoming Report)
Market Definition:
The global Vital Organs Support Systems and Medical Bionics Market size was valued at USD 33.88 billion in 2019 and is predicted to reach USD 93.80 billion by 2030, with a CAGR of 9.7% from 2020-2030.
The Organ Support System comprises of artificial organs that are designed to perform the function of natural human organs, and are utilized as a substitute of lost body organ Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Metagenomics Market by Product (Instrument & Software and Consumable), Technology (Bioinformatics and Sequencing), and Application (Infectious Disease Diagnosis, Environmental Remediation, Biotechnology, Gut Microbe Characterization, Biofuel, and Agriculture), Global Opportunity Analysis and Industry Forecast, 2020 – 2030 (Published Report)
Market Definition:
At an estimated value of over USD 0.275 billion in 2019, the Global Metagenomics Market is predicted to thrive at a CAGR of 14.5% and valued at over USD 1.22 billion over the forecast year 2020-2030.
Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microb Publish Date: Dec 2020
Single User:
3975 3776
Multi Users:
4975 4726
|
Artificial Tissue Market by Tissue Type (Bone Tissue, Skin Tissue, Adipose Tissue, Nerve Tissue, Cartilage Tissue, Liver Tissue and Other), by Material (Synthetic and Natural) and by Application (Skin Reconstruction, Adipose Regeneration, Cardiology & Vascular, Neurology, Urology, Orthopedics, Musculoskeletal & Spine, GI, Gynecology and Others)- Global Opportunity Analysis and Industry Forecast 2022-2030 (Upcoming Report)
Market Definition:
The Artificial Tissue Market size was valued at USD XX billion in 2021 and is expected to reach USD XX billion by 2030 with a CAGR of XX% from 2022-2030.
Artificial tissue is prepared in labs but exhibits property of a live tissue, thus it is used as a substitute of a natural tissue. Fabrication of artificial tissue is done with help of numerous bio-fabrication techniques. Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
CRISPR Cas9 Market by Product (Kits & Enzymes, Vector-Based Cas, DNA-Free Cas, Antibodies, Libraries, Design Tool, and Others), by Service (Cell Line Engineering, gRNA Design, Microbial Gene Editing, and DNA Synthesis), by Application (Biomedical, Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Agricultural, and Others), and by End User (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs)) – Global Opportunity Analysis and Industry Forecast, 2023–2030 (Upcoming Report)
Market Definition:
The CRISPR Cas9 Market size was valued at USD 2.94 billion in 2022, and is predicted to reach USD 12.22 billion by 2030, with a CAGR of 19.52% from 2023 to 2030. CRISPR Cas9 is an enzyme and genome-editing tool used by researchers to modify gene function and alter DNA sequences.
Also, it was adapted from a naturally-occurring genome editing system in bacteria and these ba Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Biotechnology Equipment Market by Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, Medical Lasers, and Others), by End-User (Pharmaceutical Companies, Government & Academic Institutions, Hospitals & Healthcare Facilities, and Others), by Application (Life Science, Clinical Diagnostics, Quality Management, Food & Beverage Testing) – Global Opportunity Analysis and Industry Forecast, 2023-2030 (Upcoming Report)
Market Definition
The Biotechnology Equipment Market was valued at USD 40.78 billion in 2021 and is predicted to reach USD 121.81 billion by 2030, expanding at a CAGR of 13.2% from 2023 to 2030.
Biotechnology can be defined as the branch of science that deals with the application of biological techniques for human welfare. It entails the enzymatic modification of genes, which results in the Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
North America Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
North Early Toxicity Testing Market was valued at USD 2.48 billion in 2022, and is predicted to reach USD 4.30 billion by 2030, with a CAGR of 6.15% from 2023 to 2030.
Early toxicity testing is a process that involves evaluating the potential toxicity or adverse effects of drugs, chemicals, or other substances at an early stage of development, typically in vitro or in anima Publish Date: Aug 2023
Single User:
2975 2826
Multi Users:
3975 3776
|
U.S. Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
U.S. Early Toxicity Testing Market was valued at USD 2.42 billion in 2022, and is predicted to reach USD 4.14 billion by 2030, with a CAGR of 6.02% from 2023 to 2030.
Early toxicity testing is a fundamental procedure encompassing the evaluation of potential toxicity or detrimental impacts arising from drugs, chemicals, or various substances during their preliminary developm Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Canada Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Canada Early Toxicity Testing Market was valued at USD 55.37 million in 2022, and is predicted to reach USD 124.39 million by 2030, with a CAGR of 9.15% from 2023 to 2030.
Early toxicity testing is a pivotal procedure that involves assessing the potential harmful effects or toxicity of drugs, chemicals, or substances at their initial stages of development. This comprehensiv Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Mexico Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Mexico Early Toxicity Testing Market was valued at USD 8.69 million in 2022, and is predicted to reach USD 36.16 million by 2030, with a CAGR of 16.07% from 2023 to 2030.
Early toxicity testing is a process that involves evaluating the potential toxicity or adverse effects of drugs, chemicals, or other substances at an early stage of development, typically in vitro or in an Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Europe Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Europe Early Toxicity Testing Market was valued at USD 1.07 billion in 2022, and is predicted to reach USD 2.19 billion by 2030, with a CAGR of 8.04% from 2023 to 2030.
Early toxicity testing is a fundamental procedure aimed at assessing the potential toxicity or adverse effects of drugs, chemicals, or various substances during their preliminary developmental stages. Typica Publish Date: Aug 2023
Single User:
2975 2826
Multi Users:
3975 3776
|
Germany Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Germany Early Toxicity Testing Market was valued at USD 246.68 million in 2022, and is predicted to reach USD 422.28 million by 2030, with a CAGR of 5.95% from 2023 to 2030.
Early toxicity testing is a fundamental procedure aimed at assessing the potential toxicity or adverse effects of drugs, chemicals, or various substances during their preliminary developmental stages. T Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
UK Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
UK Early Toxicity Testing Market was valued at USD 158.42 million in 2022, and is predicted to reach USD 289.77 million by 2030, with a CAGR of 6.73% from 2023 to 2030.
Early toxicity testing is a core process designed to evaluate the potential toxicity or detrimental impacts arising from drugs, chemicals, or substances in their initial developmental phases. This comprehens Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
France Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
France Early Toxicity Testing Market was valued at USD 129.68 million in 2022, and is predicted to reach USD 259.76 million by 2030, with a CAGR of 7.81% from 2023 to 2030.
Early toxicity testing is a fundamental procedure aimed at assessing the potential toxicity or adverse effects of drugs, chemicals, or various substances during their preliminary developmental stages. Ty Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Spain Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Spain Early Toxicity Testing Market was valued at USD 35.3 million in 2022, and is predicted to reach USD 99.66 million by 2030, with a CAGR of 11.8% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages of deve Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Italy Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Italy Early Toxicity Testing Market was valued at USD 46.67 million in 2022, and is predicted to reach USD 100.09 million by 2030, with a CAGR of 8.61% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages of de Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Netherlands Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Netherlands Early Toxicity Testing Market was valued at USD 44.95 million in 2022, and is predicted to reach USD 106.45 million by 2030, with a CAGR of 9.78% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Denmark Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Denmark Early Toxicity Testing Market was valued at USD 18.68 million in 2022, and is predicted to reach USD 67.9 million by 2030, with a CAGR of 14.7% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages of de Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Finland Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Finland Early Toxicity Testing Market was valued at USD 5.27 million in 2022, and is predicted to reach USD 33.29 million by 2030, with a CAGR of 20.8% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages of de Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Norway Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Norway Early Toxicity Testing Market was valued at USD 32.19 million in 2022, and is predicted to reach USD 83.45 million by 2030, with a CAGR of 10.84% from 2023 to 2030.
Early toxicity testing serves as a crucial step in the evaluation of potential drugs, chemicals, or substances, aiming to detect and assess any harmful effects or toxicity during their initial stages of d Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Sweden Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Sweden Early Toxicity Testing Market was valued at USD 3.66 million in 2022, and is predicted to reach USD 19.93 million by 2030, with a CAGR of 19.26% from 2023 to 2030.
Early toxicity testing is a process that involves evaluating the potential toxicity or adverse effects of drugs, chemicals, or other substances at an early stage of development, typically in vitro or in an Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Russia Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Russia Early Toxicity Testing Market was valued at USD 21.15 million in 2022, and is predicted to reach USD 61.98 million by 2030, with a CAGR of 12.28% from 2023 to 2030.
Early toxicity testing is a process that involves evaluating the potential toxicity or adverse effects of drugs, chemicals, or other substances at an early stage of development, typically in vitro or in a Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Asia-Pacific Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Asia-Pacific Early Toxicity Testing Market was valued at USD 5.10 billion in 2022, and is predicted to reach USD 7.55 billion by 2030, with a CAGR of 4.33% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial development Publish Date: Aug 2023
Single User:
2975 2826
Multi Users:
3975 3776
|
China Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
China Early Toxicity Testing Market was valued at USD 4.37 billion in 2022, and is predicted to reach USD 6.05 billion by 2030, with a CAGR of 3.56% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmental stag Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Japan Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Japan Early Toxicity Testing Market was valued at USD 354.14 million in 2022, and is predicted to reach USD 418.31 million by 2030, with a CAGR of 1.76% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmental Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
India Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
India Early Toxicity Testing Market was valued at USD 32.1 million in 2022, and is predicted to reach USD 120.81 million by 2030, with a CAGR of 14.69% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmental s Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Australia Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Australia Early Toxicity Testing Market was valued at USD 63.74 million in 2022, and is predicted to reach USD 151.77 million by 2030, with a CAGR of 9.71% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial development Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
South Korea Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
South Korea Early Toxicity Testing Market was valued at USD 34.14 million in 2022, and is predicted to reach USD 115.53 million by 2030, with a CAGR of 13.56% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developm Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Thailand Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Thailand Early Toxicity Testing Market was valued at USD 25.47 million in 2022, and is predicted to reach USD 136.67 million by 2030, with a CAGR of 18.29% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial development Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Taiwan Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Taiwan Early Toxicity Testing Market was valued at USD 29.55 million in 2022, and is predicted to reach USD 117.04 million by 2030, with a CAGR of 15.22% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmental Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Indonesia Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Indonesia Early Toxicity Testing Market was valued at USD 65.27 million in 2022, and is predicted to reach USD 147.99 million by 2030, with a CAGR of 9.17% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial development Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Singapore Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Singapore Early Toxicity Testing Market was valued at USD 87.22 million in 2022, and is predicted to reach USD 166.12 million by 2030, with a CAGR of 7.2% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmenta Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Latin America Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Latin America Early Toxicity Testing Market was valued at USD 95.91 million in 2022, and is predicted to reach USD 133.45 million by 2030, with a CAGR of 3.61% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial develop Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Middle East Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Middle East Early Toxicity Testing Market was valued at USD 138.87 million in 2022, and is predicted to reach USD 169.65 million by 2030, with a CAGR of 2.14% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developm Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Africa Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 (Published Report)
Market Definition
Africa Early Toxicity Testing Market was valued at USD 28.43 million in 2022, and is predicted to reach USD 42.27 million by 2030, with a CAGR of 4.35% from 2023 to 2030.
Early toxicity testing is a crucial procedure that entails the assessment of potential harmful effects or toxicity associated with drugs, chemicals, or other substances during their initial developmental s Publish Date: Aug 2023
Single User:
1575 1496
Multi Users:
2575 2446
|
Genome (DNA) Sequencing Market by Product Type (Consumable, Instrument, and Service), by Type (Whole Genome Sequencing, Exome Sequencing, and Targeted Sequencing), by Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), by Application (Biomarkers and Cancer, Research, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Agriculture & Animal Research, and Others), and by End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others) – Global Opportunity Analysis and Industry Forecast 2023-2030 (Upcoming Report)
Market Definition
The global Genome (DNA) Sequencing Market size was valued at USD 10.49 billion in 2022 and is predicted to reach USD 42.28 billion by 2030 with a CAGR of 22% from 2023-2030. Genome (DNA) sequencing refers to a technology that enables the sequencing of multiple DNA strands through massive parallelism. It is the process of analyzing the sample of DNA that is taken from Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Stem Cell Market by Cell Type (Adult Stem Cell, Embryonic Stem Cell (ESCs), Mesenchymal Stem Cells (MSCs), Induced Pluripotent Stem Cells (iPSCs), and Others), by Source (Autologous and Allogenic), by Treatment Type (Allogeneic Stem Cell Therapy, Auto logic Stem Cell Therapy, Syngeneic Stem Cell Therapy, and Others), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion, Sub-Culture, and Others), by Application (Regenerative Medicines and Drug Discovery & Development), and by End-User (Hospitals, Pharmaceutical & Biotechnology Companies, Cell & Tissue Banks, Academic & Research Institutes, and Others) – Global Opportunity Analysis and Industry Forecast 2023-2030 (Upcoming Report)
Market Definition
The Stem Cell Market size was valued at USD 13.70 billion in 2022 and is predicted to reach USD 37.15 billion by 2030 with a CAGR of 15.3% from 2023-2030.
Stem cells are versatile and essential cellular components that underpin biological development and maintenance, characterized by their unique capability to self-renew and generate both specialized cells and identical ste Publish Date: Sep 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
PAD Vascular Doppler Market by Portability (Handheld Doppler Ultrasound System and Trolley Based Doppler Ultrasound System), by Application (Obstetrician Gynecologist, Radiology, Cardiology, and Others), by End User (Hospitals, Clinics, Diagnostics Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024–2030 (Upcoming Report)
Market Definition
The PAD Vascular Doppler Market size was valued at USD 8.48 billion in 2023 and is predicted to reach USD 12.80 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. Peripheral Arterial Disease (PAD) Vascular Doppler is a medical device used to evaluate blood flow in arteries and veins located in the arms, legs, and neck. The doppler uses high-frequency ultrasound techno Publish Date: Oct 2023
Single User:
3975 3776
Multi Users:
4975 4726
|
Leukemia Therapeutics Market by Type of Leukemia (Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia (CML), and Others), by Treatment Type (Chemotherapy, and Targeted Therapy), by Route of Administration (Oral Mode and Injectable Mode), and by Distribution Channel (Hospital Pharmacy, and Retail Pharmacy) – Global Opportunity Analysis and Industry Forecast, 2024–2030 (Upcoming Report)
Market Definition
The Leukemia Therapeutics Market size was valued at USD 17.34 billion in 2023, and is predicted to reach USD 29.05 billion by 2030, with a CAGR of 9.0% from 2024 to 2030. Leukemia, also known as blood cancer impacts the blood and bone marrow. It primarily involves the uncontrolled growth of abnormal white blood cells that are in charge for fighting contamin Publish Date: Nov 2023
Single User:
3975 3776
Multi Users:
4975 4726
|